{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T04:13:27Z","timestamp":1742271207504,"version":"3.40.1"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jdcr.2024.10.037","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T17:01:00Z","timestamp":1735232460000},"page":"28-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma"],"prefix":"10.1016","volume":"57","author":[{"given":"Daniel S.","family":"Alicea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijal","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth N.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2024.10.037_bib1","first-page":"123","article-title":"Cutaneous toxicities of immune checkpoint inhibitors: the role of the dermatologist","volume":"93","author":"Tattersall","year":"2020","journal-title":"Yale J Biol Med"},{"issue":"3","key":"10.1016\/j.jdcr.2024.10.037_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic reactions to immune checkpoint inhibitors : skin toxicities and immunotherapy","volume":"19","author":"Sibaud","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"10.1016\/j.jdcr.2024.10.037_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s12094-018-1891-7","article-title":"Cutaneous toxicities of new treatments for melanoma","volume":"20","author":"Boada","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"10.1016\/j.jdcr.2024.10.037_bib4","article-title":"Pembrolizumab-induced eruptive keratoacanthomas and lichen planus in a lung cancer patient","volume":"15","author":"Tembunde","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jdcr.2024.10.037_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1159\/000518313","article-title":"Skin deep: a fascinating case report of immunotherapy-triggered, treatment-refractory autoimmune lichen planus and keratoacanthoma","volume":"14","author":"Preti","year":"2021","journal-title":"Case Rep Oncol"},{"issue":"4","key":"10.1016\/j.jdcr.2024.10.037_bib6","article-title":"Nivolumab-induced hypertrophic lichen planus and eruptive keratoacanthomas","volume":"81","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2024.10.037_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjd.20389","article-title":"A clinical and biological review of keratoacanthoma","volume":"185","author":"Tisack","year":"2021","journal-title":"Br J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624005009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624005009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:41:18Z","timestamp":1742229678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624005009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":7,"alternative-id":["S2352512624005009"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.10.037","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}